	Three Months Ended						Nine Months Ended
	September 30,						September 30,
(US$ in millions, except for share data)	2015			2014			2015			2014
Income from continuing operations, net of tax	$	213		$	277		$	551		$	525
Net (income) loss attributable to noncontrolling interests	5			(10		)	1			7

Income (loss) from continuing operations attributable to Bunge	218			267			552			532

Other redeemable obligations (1)	(2		)	(2		)	(13		)	(15		)
Convertible preference share dividends	(8		)	(8		)	(25		)	(25		)
Income (loss) from discontinued operations, net of tax	21			27			36			37

Net income (loss) available to Bunge common shareholders	$	229		$	284		$	550		$	529


Weighted-average number of common shares outstanding:
Basic	143,361,057			145,528,313			144,077,505			146,493,870
Effect of dilutive shares:
—stock options and awards	638,412			981,122			822,124			958,505
—convertible preference shares	7,794,930			7,680,390			7,794,930			7,680,390

Diluted (2)	151,794,399			154,189,825			152,694,559			155,132,765


Basic earnings per common share:
Net income (loss) from continuing operations	$	1.45		$	1.77		$	3.57		$	3.36
Net income (loss) from discontinued operations	0.14			0.19			0.25			0.25

Net income (loss) to Bunge attributable to common shareholders—basic	$	1.59		$	1.96		$	3.82		$	3.61


Diluted earnings per common share:
Net income (loss) from continuing operations	$	1.42		$	1.73		$	3.53		$	3.34
Net income (loss) from discontinued operations	0.14			0.17			0.24			0.24

Net income (loss) attributable to Bunge common shareholders—diluted	$	1.56		$	1.90		$	3.77		$	3.58

(1)

Accretion of redeemable noncontrolling interest of $2 million and $2 million for the three months ended September 30, 2015 and 2014, respectively, and $13 million and $15 million for the nine months ended September 30, 2015 and 2014, respectively, relates to a non-fair value variable put arrangement whereby the noncontrolling interest holder may require Bunge to purchase the remaining shares of an oilseed processing operation in Central and Eastern Europe. Accretion for the respective periods includes the effect of losses incurred by the operations for the three and nine months ended September 30, 2015, and 2014, respectively.

(2)

Approximately 3 million and 2 million outstanding stock options and contingently issuable restricted stock units were not dilutive and not included in the weighted-average number of common shares outstanding for the three and nine months ended September 30, 2015.

Approximately 2 million and 3 million outstanding stock options and contingently issuable restricted stock units were not dilutive and not included in the weighted-average number of common shares outstanding for the three and nine months ended September 30, 2014.